Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies. - Doshi BS; Markmann CA; Novak N; Juarez Rojas S; Davidson R; Chau JQ; Wang W; Carrig S; Martos Rus C; Samelson-Jones BJ; Small JC; Bhoj VG; et al. (Molecular therapy : the journal of the American Society of Gene Therapy, 2025)